Dr. Ming Chen, MD, MSc, PhD, is a renowned clinical geneticist and medical researcher, celebrated for his transformative contributions to genomic medicine and medical research. As the Chief Medical Director of Changhua Christian Hospital in Taiwan, he has spearheaded advancements in genomic diagnostics, elevating Taiwan’s healthcare standards to global levels. His leadership extends to multiple roles, including Head of the Department of Genomic Medicine and Medical Research, where he integrates cutting-edge research with clinical applications. Dr. Chen is highly regarded for his pioneering work in reproductive genetics, prenatal diagnostics, and the molecular underpinnings of rare genetic disorders, establishing him as a leading figure in the Asia-Pacific region.
Professional Profile
Education
Dr. Chen’s academic journey reflects an unwavering commitment to excellence. He earned his medical degree from National Taiwan University, laying a strong foundation in clinical medicine. Furthering his specialization, he pursued a master’s degree in medical genetics at the University of Glasgow, Scotland, graduating with distinction. His PhD in Life Sciences from National Taiwan University allowed him to delve deeply into genomic research, equipping him with the expertise to bridge academic research and clinical practice. This robust educational background has been instrumental in shaping his multidisciplinary approach to solving complex medical challenges.
Experience
With over two decades of experience, Dr. Chen has held pivotal positions in academic and medical institutions. As an adjunct professor at National Taiwan University, Tunghai University, and Dayeh University, he has mentored countless students and professionals. His clinical and administrative roles at Changhua Christian Hospital have been transformative, particularly in establishing Taiwan’s first CAP-accredited independent genetics diagnostic laboratory. Under his leadership, the hospital has become a hub for advanced genomic technologies, including next-generation sequencing and cytogenetics. Additionally, his role as a board member for multiple professional societies and biotech organizations highlights his influence in shaping the future of genomic medicine.
Research Interests
Dr. Chen’s research is centered on genomic medicine, reproductive genetics, and evolutionary biology. He is particularly interested in applying molecular and cytogenetic tools to diagnose and treat rare genetic disorders. His innovative work in prenatal diagnostics, such as non-invasive prenatal testing (NIPT) and preimplantation genetic screening (PGS), has significantly improved outcomes for high-risk pregnancies. Furthermore, his exploration of de novo genetic variants and their implications in inherited disorders has contributed to a deeper understanding of the genetic basis of diseases. Dr. Chen is also committed to translating research findings into practical solutions that enhance patient care.
Awards
Dr. Chen has received numerous accolades for his contributions to medical science and education. Notable among these is the Distinguished Alumni Award from Taipei Fu-Hsing Private School, recognizing his outstanding achievements in genomic medicine. His election to the prestigious Fetoscopy Working Group as the sole member from Taiwan underscores his global recognition. Additionally, his roles in professional societies, including the Taiwan Society of Human Genetics and the Taiwan Society of Perinatology, reflect his leadership and dedication to advancing medical genetics.
Publications
“Genetic investigations of autosomal recessive inherited ichthyosis impressed by fetal ultrasound: exome sequencing and haplotype linkage analysis” – Taiwanese Journal of Obstetrics & Gynecology (2025). Cited by: 22. 🧬
“De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study” – International Journal of Molecular Sciences (2024). Cited by: 15. 🩺
“Outcome and etiology of fetal pleural effusion, fetal ascites, and hydrops fetalis after fetal intervention” – Ultrasound in Obstetrics & Gynecology (2024). Cited by: 12. 🤰
“Low-level mosaic trisomy 13 at amniocentesis in a pregnancy associated with a positive NIPT result” – Taiwanese Journal of Obstetrics & Gynecology (2023). Cited by: 10. 👶
“Fetal ascites in third trimester as novel prenatal finding in Bardet-Biedl syndrome” – Ultrasound in Obstetrics & Gynecology (2023). Cited by: 8. 🧩
“Origin and timing of de novo variants implicated in type 2 von Willebrand disease” – Journal of Cellular and Molecular Medicine (2022). Cited by: 18. 🔬
“Isolation of TTF-1 Positive Circulating Tumor Cells for Single-Cell Sequencing” – International Journal of Molecular Sciences (2022). Cited by: 20. 🧪
Conclusion
Dr. Ming Chen’s unparalleled dedication to genomic medicine, coupled with his innovative research and leadership, has positioned him as a trailblazer in the medical field. His work has not only elevated Taiwan’s prominence in genomic research but also had a far-reaching impact on global healthcare. As a mentor, researcher, and clinician, Dr. Chen exemplifies the qualities of a distinguished researcher, making him a deserving candidate for the Best Researcher Award. His commitment to excellence and transformative contributions continue to inspire the next generation of medical scientist